How to Start
To make an appointment, you need to enter your Hong Kong identity card number as the identity document number and input your day and year of birth as well. If you are making an appointment for your child, please provide the Hong Kong identity card number of the child. You also have to enter a personalised 4-digit enquiry code for subsequent change, cancellation or enquiry about your appointment.
You can select your appointment for the next 24 working days (Monday to Saturday, except public holidays). The result of your booking is subject to the availability of quota of each Smart Identity Card Replacement Centre (SIDCC).
Golden State Welcomes Wealth Manager, John Pak of Vector3 Wealth Management in Santa Cruz, CA
Golden State Welcomes Wealth Manager, John Pak of Vector3 Wealth Management in Santa Cruz, CA
South Coast Metro, Calif., Dec. 15, 2020 Golden State, a registered investment adviser, is pleased to announce that John Pak of Vector3 Wealth Management has joined the team. With the intent to transition over $90 million in client assets, John will use this as a launching pad to continue to grow his business. He comes to the firm from Edge Wealth Management where he served as Senior Financial Advisor since 2009. Prior to that John was CEO at Black Pearl Asset Management, Senior Portfolio Manager and Securities Analyst at Turner Investment Partners where he co-managed three highly rated mutual funds as well as portfolios for Taft Hartley and ERISA Defined Benefit plans. Prior to Turner Investment Partners, John was head of Trade Desk at Tuttle, the largest independent hedger of interest rate ris
Advantech Year-in-Review: 2020 Highlights
Advantech Year-in-Review: 2020 Highlights
Advantech, a global leader of advanced IoT intelligence systems and embedded platforms, marked a successful 2020despite the years global pandemic challengeswith prestigious honors and recognitions, as well as new solutions to help organizations around the world combat COVID. As a member of the Intel Network Builders program, Advantech helps drive digital innovations that simplify and accelerate network transformation. By demonstrating its outstanding innovations and business acumen in alignment with Intel Network Builders mission, Advantech was honored as one of
Intels 2020 Winners Circle Members. Additionally, Advantechs MIC-730AI Edge AI inference System was a recipient of a
SATLANTIS Kick-starts the First Project Under the European Defence Industrial Development Programme (EDIDP)
SATLANTIS Kick-starts the First Project Under the European Defence Industrial Development Programme (EDIDP) The Spanish company SATLANTIS MICROSATS signed in October a grant agreement with the European Commission within the first edition of the EDIDP Programme (European Defence Industrial Development Programme) through the project OPTISSE. In it, SATLANTIS is leading a Consortium of five companies from five European countries: ColomboSky (Italy), Syrlinks (France), Astro- und Feinwerktechnik (Germany), Solaris Optics (Poland), plus Everis Aerospace and Defense (Spain) as associated partner. The Call for Proposal addressed innovative SMEs and required the support of the Ministries of Defence whose companies are represented in the Consortium. Therefore, all the Ministries will be involved in the project, acting as potential final users and generating the operational require
Uni-Bio Science Group Receives BE Certification for PINUP® (Voriconazole Tablets) by the NMPA
Uni-Bio Science Group Receives BE Certification for PINUP® (Voriconazole Tablets) by the NMPA
HONG KONG SAR – EQS Newswire – 16 December 2020 – A fully integrated biopharmaceutical company Uni-Bio Science Group Limited (the “Company”, together with its subsidiaries, the “Group”; Stock code: 00690.HK) is pleased to announce that PINUP® (Voriconazole Tablets) has been successfully approved by the National Medical Products Administration (“NMPA”) for Bioequivalence (“BE”) certification with the acceptance number of H20055751 (50mg). In order to meet the national requirements for improving the quality of generic drugs, the Group launched the quality advancement and therapeutic effect BE experiment in 2018. In August 2019, the Group had completed all the BE experiments, and had submitted the results to the NMPA. The approval will facilitate its hospital tenders and